2018
DOI: 10.1002/hbm.24186
|View full text |Cite
|
Sign up to set email alerts
|

Effects ofSYN1Q555Xmutation on cortical gray matter microstructure

Abstract: A new Q555X mutation on the SYN1 gene was recently found in several members of a family segregating dyslexia, epilepsy, and autism spectrum disorder. To describe the effects of this mutation on cortical gray matter microstructure, we performed a surface-based group study using novel diffusion and quantitative multiparametric imaging on 13 SYN1 mutation carriers and 13 age- and sex-matched controls. Specifically, diffusion kurtosis imaging (DKI) and neurite orientation and dispersion and density imaging (NODDI)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 113 publications
0
2
0
Order By: Relevance
“…81 Billiet and colleagues 82 found reduced ND in the "unidentified bright objects" in neurofibromatosis type 1. Other studies focused on perinatal encephalopathy, 83 SYN1Q555X mutation, 84 C9orf72 disease, 85 and sarcoma survivors. 86 Spine NODDI is also feasible for evaluating the human spinal cord.…”
Section: Other Brain Disordersmentioning
confidence: 99%
“…81 Billiet and colleagues 82 found reduced ND in the "unidentified bright objects" in neurofibromatosis type 1. Other studies focused on perinatal encephalopathy, 83 SYN1Q555X mutation, 84 C9orf72 disease, 85 and sarcoma survivors. 86 Spine NODDI is also feasible for evaluating the human spinal cord.…”
Section: Other Brain Disordersmentioning
confidence: 99%
“…Here, we focus on the X-linked gene SYN1. Pathogenic variants in this gene have been recurrently reported in individual cases and families ( Garcia et al 2004 ; Fassio et al 2011 ; Guarnieri et al 2017 ; Xiong et al 2021 ; Zhou et al 2021 ; Butler et al 2017 ; Lindy et al 2018 ; Nguyen et al 2015 ; Rossi et al 2017 ; Peron et al 2018 ; Fernandez-Marmiesse et al 2019 ; Darvish et al 2020 ; Ibarluzea et al 2020 ; Mojarad et al 2021 ; van der Ven et al 2021 ; Stranneheim et al 2021 ; Yang et al 2020 ; Cabana et al 2018 ). Epilepsy, learning disabilities, speech delay, intellectual disability (ID), and autism spectrum disorder (ASD) are the most frequent clinical manifestations associated with SYN1 variants ( Longhena et al 2021 ; John et al 2021 ; Accogli et al 2021 ), but an extensive comparison of the clinical features and genotype-phenotype correlations are missing.…”
Section: Introductionmentioning
confidence: 99%